Medication adherence in patients with diabetes mellitus: does physician drug dispensing enhance quality of care? Evidence from a large health claims database in Switzerland
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The drug-dispensing channel is a scarcely explored determinant of medication adherence, which is considered as a key indicator for the quality of care among patients with diabetes mellitus. In this study, we investigated the difference in adherence between diabetes patients who obtained their medication directly from a prescribing physician (physician dispensing [PD]) or via a pharmacy. METHODS: A retrospective cohort study was conducted using a large health care claims database from 2011 to 2014. Patients with diabetes of all ages and receiving at least one oral antidiabetic drug (OAD) prescription were included. We calculated patients' individual adherence to OADs defined as the proportion of days covered (PDC), which was measured over 1 year after patient identification. Good adherence was defined as PDC ≥80%. Multivariate logistic regression analysis was performed to assess the relationship between the PDC and the dispensing channel (PD, pharmacy). RESULTS: We identified a total of 10,430 patients prescribed drugs by a dispensing physician and 16,292 patients receiving drugs from a pharmacy. Medication adherence was poor in both patient groups: ~40% of the study population attained good adherence to OADs. We found no significant impact of PD on the adherence level in diabetes patients. Covariates associated significantly with good adherence were older age groups, male sex, occurrence of comorbidity and combined diabetes drug therapy. CONCLUSION: In conclusion, adherence to antihyperglycemic medication is suboptimal among patients with diabetes. The results of this study provide evidence that the dispensing channel does not have an impact on adherence in Switzerland. Certainly, medication adherence needs to be improved in both supply settings. Physicians as well as pharmacists are encouraged to develop and implement useful tools to increase patients' adherence behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suboptimal medication-taking behavior and low rates of continued medication use, or what is termed ' persistence to therapy plans, ' affects almost half of people with type 2 diabetes, leading to suboptimal glycemic and CVD risk factor control as well as increased risks of diabetes complications, mortality, and hospital admissions and increased health care costs (58 -62).”
From Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2022) · cites this paper as [59]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Kennedy, L. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70021-0 · Cited by 1,195
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1836 · Cited by 1,135
Adherence to diabetes medication: a systematic review
Krass, I., Schieback, P., & Dhippayom, T. (2015) · Diabetic Medicine · doi:10.1111/dme.12651 · Cited by 453 · cited 3×
“11,12 A .”
A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes
Asche, C., LaFleur, J., & Conner, C. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.01.019 · Cited by 420
Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall, M., Williams, L. K., Potts, L. A., Divine, G., Xi, H., & Elston Lafata, J. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2800 · Cited by 404 · cited 1×
“4–10 Assessments of adherence rates to antidiabetic drugs showed variable results, but indicated a strong tendency toward poor medication adherence.”
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E. (2015) · Diabetes Care · doi:10.2337/dc14-2098 · Cited by 388 · cited 1×
“15 Moreover, little evidence exists on system-related factors such as the dispensing channel.”
Measuring concurrent adherence to multiple related medications.
Choudhry, N. K., Shrank, W. H., Levin, R., Lee, J. L.-Y., Jan, S. A., Brookhart, M. A., & Solomon, D. H. (2009) · PubMed · Cited by 379
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 318
Oral antidiabetic medication adherence and glycemic control in managed care.
Rozenfeld, Y., Hunt, J. S., Plauschinat, C. A., & Wong, K. S. (2008) · PubMed · Cited by 299
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226 · cited 2×
“22,23 The defined daily doses for diabetes drug classes recommended by the WHO were used to determine the number of days supplied for each oral antihyperglycemic drug class.”
Huber, C. A., Szucs, T. D., Rapold, R., & Reich, O. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-1030 · Cited by 213 · cited 1×
“According to the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system, we used prescription data to identify patients with chronic diseases.(20,21) According to patients’ drug treatment, we additionally classified the intensity of diabetes drug therapy (over 1 year after index pr…”
Self-citationFederalism and regional health care expenditures: an empirical analysis for the Swiss cantons
Crivelli, L., Filippini, M., & Mosca, I. (2006) · Health Economics · doi:10.1002/hec.1072 · Cited by 181 · cited 2×
“16,17 Thus, since the Swiss health care system has its own cantonal regulation of drug dispensing, namely by the physicians in private practice, it is ideally suited for the investigation of the effect of different supply channels on medication adherence.”
Chen, C.-C., Tseng, C.-H., & Cheng, S.-H. (2013) · Medical Care · doi:10.1097/mlr.0b013e31827da5b9 · Cited by 181
A Systematic Review of Adherence With Medications for Diabetes
Wens, J., Vermeire, E., Van Royen, P., & Hearnshaw, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2284 · Cited by 171
Reich, O., Weins, C., Schusterschitz, C., & Thöni, M. (2011) · The European Journal of Health Economics · doi:10.1007/s10198-011-0299-x · Cited by 60 · cited 2×
“16,17 Thus, since the Swiss health care system has its own cantonal regulation of drug dispensing, namely by the physicians in private practice, it is ideally suited for the investigation of the effect of different supply channels on medication adherence.”
Self-citationMail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes
Zhang, L., Zakharyan, A., Stockl, K. M., Harada, A. S. M., Curtis, B. S., & Solow, B. K. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.598200 · Cited by 53 · cited 2×
“24,25 To the best of our knowledge, this study is the first that has compared the impact of two fundamental different structures of dispensing channel on medication adherence, as is given in the Swiss health care system.”
Does Physician Dispensing Increase Drug Expenditures? Empirical Evidence from Switzerland
Kaiser, B., & Schmid, C. (2014) · Health Economics · doi:10.1002/hec.3124 · Cited by 52 · cited 1×
“Previous national research has already suggested an effect of PD on health care expenditures, but evidence on the quality of care between PD and the pharmacy channel is very scarce.(18,19) Medication adherence can be seen as a useful indicator to capture quality in diabetes care and furthermore to assess potential qua…”
Juarez, D. T., Tan, C., Davis, J., & Mau, M. (2013) · Journal of Pharmaceutical Health Services Research · doi:10.1111/jphs.12016 · Cited by 47
Huber, C. A., Rapold, R., Brüngger, B., Reich, O., & Rosemann, T. (2016) · Medicine · doi:10.1097/md.0000000000003994 · Cited by 42 · cited 2×
“The detailed study design has been described elsewhere.(6) Patients who received more than 50% of the drugs per year directly from a physician in private practice were assigned to the PD group.”
Self-citationIyengar, R. N., Balagere, D. S., Henderson, R. R., LeFrancois, A. L., Rabbitt, R. M., & Frazee, S. G. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.8.851 · Cited by 35 · cited 1×
“24,25 To the best of our knowledge, this study is the first that has compared the impact of two fundamental different structures of dispensing channel on medication adherence, as is given in the Swiss health care system.”
Blozik, E., Rapold, R., & Reich, O. (2015) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s78179 · Cited by 17 · cited 1×
“Previous national research has already suggested an effect of PD on health care expenditures, but evidence on the quality of care between PD and the pharmacy channel is very scarce.(18,19) Medication adherence can be seen as a useful indicator to capture quality in diabetes care and furthermore to assess potential qua…”
Self-citation
Cited by
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetes Care · doi:10.2337/dci18-0033 · Cited by 3,518
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetes Care · doi:10.2337/dci22-0034 · Cited by 2,104
Davies, M. J., D’Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J., & Buse, J. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4729-5 · Cited by 1,455
Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05787-2 · Cited by 1,048
Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. (2019) · BMC Endocrine Disorders · doi:10.1186/s12902-019-0360-9 · Cited by 147
Metadata
- Authors
- Huber, C. A., & Reich, O.
- Affiliations
- Helsana Group (Switzerland) (CH)
- Corresponding author
- Huber, Carola A
- ORCID
- Huber, Carola A
- Venue
- Patient Preference and Adherence
- Publisher
- Informa UK Limited
- Published
- 2016-09
- Volume
- Volume 10
- Pages
- 1803-1809
- ISSN
- 1177-889X (ISSN-L)
- PMC
- PMC5029845
- OpenAlex
- W2520169821
- Cited by
- 42
- References
- 27
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 4 · 2020: 7 · 2019: 4 · 2018: 4 · 2017: 2
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Patient Preference and Adherence (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- medication adherence, diabetes mellitus, oral antidiabetic drugs, physician dispensing, medication dispensing, quality of care, proportion of days covered, comorbidities, antihyperglycemic medications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
